美股新聞 標題聯播 · 近 24 小時 284 則 · 25 個來源 · 最新 9/20 06:32
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · ORMP近 30 天 2 則 · 第 1 / 1 頁
- Lifeward Publishes Updated Investor Presentation Highlighting Commercial Growth Strategy
- ORMP: Investment Gains Contributed to Strong 2Q26 EPS, While Inclusion in Russell Indexes Arguably Boosts Awareness
- Nano Dimension Appoints Nadav Kidron to Board of Directors to Chair Strategy and Capital Allocation Committee
- Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet
- ORMP: View Inclusion in Russell Indexes as Positive That Could Raise Awareness in Investment Community
- Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® Indexes
- ORMP: Strategically Acquiring Interests in Medtech & Technology Companies
- Spotlight On Oramed Pharmaceuticals And Two Other Prominent Penny Stocks
- Oramed Pharmaceuticals And Two Other Promising Penny Stocks For Savvy Investors
- Lifeward Successfully Closes on Strategic Partnership with Oramed
- Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company
- ORMP: Enabling Participation in Both ORMP & LFWD Businesses Expected to Enhance Shareholder Value
- Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company
- Oramed and Lifeward Announce Strategic Transaction
- Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。